Previous studies have also reported that activation of interferon alpha (IFNα), B-cell activating factor (BAFF), and antibodies to muscarinic acetylcholine receptors is associated with the development of SjS [34]; and that sirolimus inhibits BAFF-stimulated cell proliferation [35]. This evidence concerns the gene TNFSF13B and Schwartz-Jampel syndrome.